• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与男同性恋者相比,注射吸毒者中HIV-1合胞体诱导表型的患病率和发病率较低。

Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men.

作者信息

Spijkerman I J, Koot M, Prins M, Keet I P, van den Hoek A J, Miedema F, Coutinho R A

机构信息

Department of Public Health and Environment, Municipal Health Service, Amsterdam, The Netherlands.

出版信息

AIDS. 1995 Sep;9(9):1085-92. doi: 10.1097/00002030-199509000-00016.

DOI:10.1097/00002030-199509000-00016
PMID:8527083
Abstract

OBJECTIVE

To study the prevalence, incidence and predictive value for progression to AIDS of the HIV-1 syncytium-inducing (SI) phenotype in HIV-infected injecting drug users (IDU) compared with HIV-infected homosexual men.

DESIGN

Two prospective cohort studies on HIV-1 infection among IDU and homosexual men.

METHODS

HIV-infected IDU (n = 225) and homosexual men (n = 366) without AIDS were studied from March 1989 through December 1993. Data on laboratory markers, including the presence of SI variants, demographics, behavioural characteristics and clinical events were collected at every visit.

RESULTS

At baseline, SI variants were detected in 4% of IDU and 17% of homosexual men. During the study period 18 IDU and 68 homosexual men switched from non-SI to SI phenotype (4-year cumulative incidence, 14.6 and 28.4%, respectively) before AIDS diagnosis. Among participants with a documented date of HIV infection the cumulative incidence of SI was lower among IDU than homosexual men (4-year cumulative incidence, 6.2 and 20.7%, respectively). At AIDS diagnosis, 21% of all AIDS cases among IDU had the SI phenotype compared with 54% among homosexual men. In both risk groups an accelerated CD4 decline was found after the non-SI-to-SI switch. The SI phenotype appeared to be a predictor of AIDS (multivariate relative hazard, 5.33), independent of CD4 cell count and p24 antigen at baseline. In the multivariate time-dependent analysis, the relative hazard of SI phenotype decreased considerably, which is consistent with the hypothesis that the effect of SI phenotype on progression to AIDS is mediated by CD4 cell count.

CONCLUSION

The SI phenotype is associated with accelerated CD4 decline and progression to AIDS in both risk groups. The remarkable lower prevalence and incidence of the SI phenotype among IDU may implicate a difference in pathogenesis and natural history of HIV infection linked to transmission group.

摘要

目的

与感染HIV的同性恋男性相比,研究HIV感染的注射吸毒者(IDU)中HIV-1合胞体诱导(SI)表型的流行率、发病率及进展为艾滋病的预测价值。

设计

两项关于IDU和同性恋男性中HIV-1感染的前瞻性队列研究。

方法

1989年3月至1993年12月,对未患艾滋病的HIV感染IDU(n = 225)和同性恋男性(n = 366)进行研究。每次随访时收集实验室指标数据,包括SI变异体的存在情况、人口统计学、行为特征和临床事件。

结果

基线时,4%的IDU和17%的同性恋男性检测到SI变异体。在研究期间,18名IDU和68名同性恋男性在艾滋病诊断前从非SI表型转变为SI表型(4年累积发病率分别为14.6%和28.4%)。在有记录的HIV感染日期的参与者中,IDU中SI的累积发病率低于同性恋男性(4年累积发病率分别为6.2%和20.7%)。在艾滋病诊断时,IDU中所有艾滋病病例的21%具有SI表型,而同性恋男性中这一比例为54%。在两个风险组中,从非SI转变为SI后均发现CD4加速下降。SI表型似乎是艾滋病的一个预测指标(多变量相对风险为5.33),独立于基线时的CD4细胞计数和p24抗原。在多变量时间依赖性分析中,SI表型的相对风险大幅下降,这与SI表型对进展为艾滋病的影响是由CD4细胞计数介导的假设一致。

结论

在两个风险组中,SI表型均与CD4加速下降和进展为艾滋病有关。IDU中SI表型的流行率和发病率显著较低,这可能意味着与传播组相关的HIV感染发病机制和自然史存在差异。

相似文献

1
Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men.与男同性恋者相比,注射吸毒者中HIV-1合胞体诱导表型的患病率和发病率较低。
AIDS. 1995 Sep;9(9):1085-92. doi: 10.1097/00002030-199509000-00016.
2
Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.HIV-1 合胞体诱导表型对 CD4+ 细胞耗竭率及进展至艾滋病的预后价值。
Ann Intern Med. 1993 May 1;118(9):681-8. doi: 10.7326/0003-4819-118-9-199305010-00004.
3
Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study.对有记录的HIV-1血清转化日期的注射吸毒者和男同性恋者中疾病进展与未进展情况的比较。欧洲血清转化者研究和三大洲血清转化者研究。
AIDS. 1997 Apr;11(5):621-31. doi: 10.1097/00002030-199705000-00010.
4
Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.CD4+细胞计数<200×10⁶/L但无艾滋病定义临床疾病的HIV感染同性恋男性疾病进展的预测因素。
AIDS. 1994 Nov;8(11):1577-83. doi: 10.1097/00002030-199411000-00009.
5
Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.艾滋病进展的免疫标志物:五个艾滋病毒感染队列的一致性。多队列分析项目研讨会。第一部分。
AIDS. 1994 Jul;8(7):911-21.
6
Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology.注射吸毒者感染艾滋病毒后的生存期比男同性恋者更长:对免疫学的启示。
AIDS. 1997 Jul;11(8):1007-12. doi: 10.1097/00002030-199708000-00009.
7
Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users relative to homosexual men.
AIDS. 1996 Mar;10(3):344-5. doi: 10.1097/00002030-199603000-00020.
8
Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.泰国曼谷患者人类免疫缺陷病毒感染的临床和免疫学特征
Int J Epidemiol. 1998 Apr;27(2):289-95. doi: 10.1093/ije/27.2.289.
9
The incubation period to AIDS in injecting drug users estimated from prevalent cohort data, accounting for death prior to an AIDS diagnosis.根据现患队列数据估算的注射吸毒者患艾滋病的潜伏期,其中考虑了艾滋病诊断前的死亡情况。
AIDS. 1998 Aug 20;12(12):1537-44. doi: 10.1097/00002030-199812000-00017.
10
Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.注射吸毒者中艾滋病毒感染的进展:频繁借用注射器具者进展率较低的迹象。
AIDS. 1993 Oct;7(10):1363-70.

引用本文的文献

1
The Interplay of HIV and Autophagy in Early Infection.早期感染中HIV与自噬的相互作用
Front Microbiol. 2021 Apr 28;12:661446. doi: 10.3389/fmicb.2021.661446. eCollection 2021.
2
Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells.全球 CCR5 嗜性 HIV-1 信号转导的磷酸化蛋白质组学研究揭示了细胞蛋白质产生途径的重编程,并确定了 p70-S6K1 和 MK2 作为 HIV 反应性激酶,是 CD4+ T 细胞最佳感染所必需的。
Retrovirology. 2018 Jul 3;15(1):44. doi: 10.1186/s12977-018-0423-4.
3
Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population.
在高加索人群中,HIV-1 嗜性与 CCR5 人类单倍型 E 之间存在关联。
J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):239-44. doi: 10.1097/QAI.0000000000000127.
4
A mouse model for HIV-1 entry.HIV-1 进入的小鼠模型。
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15859-64. doi: 10.1073/pnas.1213409109. Epub 2012 Sep 10.
5
Persistence and emergence of X4 virus in HIV infection.HIV 感染中 X4 病毒的持续存在和出现。
Math Biosci Eng. 2011 Apr;8(2):605-26. doi: 10.3934/mbe.2011.8.605.
6
Selective transmission of R5 HIV-1 variants: where is the gatekeeper?R5 型 HIV-1 变异体的选择性传播:谁是守门员?
J Transl Med. 2011 Jan 27;9 Suppl 1(Suppl 1):S6. doi: 10.1186/1479-5876-9-S1-S6.
7
Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.在疾病晚期,HIV-1 亚型 A 和 CRF02_AG 频繁出现 CXCR4 嗜性——西非流行疫情不断演变的迹象。
Retrovirology. 2010 Mar 22;7:23. doi: 10.1186/1742-4690-7-23.
8
Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.慢性阿片类药物依赖与神经艾滋病的恒河猴模型:听觉脑干反应和视觉诱发电位的纵向评估
J Neuroimmune Pharmacol. 2009 Jun;4(2):260-75. doi: 10.1007/s11481-009-9149-3. Epub 2009 Mar 13.
9
Relationship between HIV coreceptor tropism and disease progression in persons with untreated chronic HIV infection.未经治疗的慢性HIV感染者中HIV共受体嗜性与疾病进展的关系。
J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):259-66. doi: 10.1097/QAI.0b013e3181989a8b.
10
Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.人类免疫缺陷病毒1型(HIV-1)gp120 V1V2和V3区域的患者体内变化对共受体使用、CC/CXC趋化因子介导的病毒抑制、可溶性CD4以及b12和2G12单克隆抗体产生不同程度的调节作用。
J Virol. 2004 Jan;78(1):524-30. doi: 10.1128/jvi.78.1.524-530.2004.